{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:47:16Z","timestamp":1793533636176,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-08341-1","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:25:57Z","timestamp":1763544357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Do we need to reconsider our antibiotic regimen for preterm premature rupture of membranes? Pathogens and perinatal outcome in PPROM"],"prefix":"10.1186","volume":"25","author":[{"given":"Livia","family":"Schuler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Christmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Brambs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ardabili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"8341_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ogc.2005.03.003","volume":"32","author":"BM Mercer","year":"2005","unstructured":"Mercer BM. Preterm premature rupture of membranes: current approaches to evaluation and management. Obstet Gynecol Clin North Am. 2005;32:411\u201328.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"8341_CR2","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/jama.1997.03550120049032","volume":"278","author":"BM Mercer","year":"1997","unstructured":"Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of child health and human development Maternal-Fetal medicine units network. JAMA. 1997;278:989\u201395.","journal-title":"JAMA"},{"issue":"9261","key":"8341_CR3","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(00)04233-1","volume":"357","author":"SL Kenyon","year":"2001","unstructured":"Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet. 2001;357(9261):979\u201388.","journal-title":"Lancet"},{"key":"8341_CR4","doi-asserted-by":"crossref","unstructured":"Kenyon S, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group. &. ORACLE - antibiotics for preterm prelabour rupture of the membranes: short-term and long-term outcomes. Acta Paediatr. 2002:9112\u201315.","DOI":"10.1111\/j.1651-2227.2002.tb00153.x"},{"key":"8341_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-8-14","volume":"8","author":"S Kenyon","year":"2008","unstructured":"Kenyon S, Brocklehurst P, Jones D, Marlow N, Salt A, Taylor D. MRC ORACLE children study. Long term outcomes following prescription of antibiotics to pregnant women with either spontaneous preterm labour or preterm rupture of the membranes. BMC Pregnancy Childbirth. 2008;8:14.","journal-title":"BMC Pregnancy Childbirth"},{"key":"8341_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.earlhumdev.2012.10.003","volume":"89","author":"JP Seliga-Siwecka","year":"2013","unstructured":"Seliga-Siwecka JP, Kornacka MK. Neonatal outcome of preterm infants born to mothers with abnormal genital tract colonisation and chorioamnionitis: a cohort study. Early Hum Dev. 2013;89:271\u20135.","journal-title":"Early Hum Dev"},{"key":"8341_CR7","doi-asserted-by":"crossref","unstructured":"Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2013:CD001058.","DOI":"10.1002\/14651858.CD001058.pub3"},{"key":"8341_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/uog.21884","volume":"55","author":"C Chatzakis","year":"2020","unstructured":"Chatzakis C, Papatheodorou S, Sarafidis K, Dinas K, Makrydimas G, Sotiriadis A. Effect on perinatal outcome of prophylactic antibiotics in preterm prelabor rupture of membranes: network meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol. 2020;55:20.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"8341_CR9","doi-asserted-by":"crossref","unstructured":"Berger R, Abele H, Bahlmann F, Doubek K, Felderhoff-M\u00fcser U, Fluhr H et al. September. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry Number 015\/025, 2022). Geburtshilfe und Frauenheilkunde. 2023;83(05):569\u2013601.","DOI":"10.1055\/a-2044-0345"},{"key":"8341_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jpeds.2018.05.048","volume":"201","author":"E Giannoni","year":"2018","unstructured":"Giannoni E, Agyeman PK, Stocker M, Posfay-Barbe KM, Heininger U, Spycher BD, et al. Neonatal sepsis of early onset, and hospital-acquired and community-acquired late onset: a prospective population-based cohort study. J Pediatr. 2018;201:106\u201314.","journal-title":"J Pediatr"},{"issue":"3","key":"8341_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/INF.0000000000002976","volume":"40","author":"N K\u00f6stlin-Gille","year":"2021","unstructured":"K\u00f6stlin-Gille N, H\u00e4rtel C, Haug C, G\u00f6pel W, Zemlin M, M\u00fcller A, et al. Epidemiology of early and late onset neonatal sepsis in very low birthweight infants: data from the German neonatal network. Pediatr Infect Dis J. 2021;40(3):255\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"8341_CR12","unstructured":"Anresis. Institut of Infectious Diseases, University of Bern, 2023: https:\/\/www.anresis.ch\/antibioticresistance\/resistance-data-human-medicine\/"},{"issue":"5","key":"8341_CR13","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.ajog.2007.12.022","volume":"198","author":"RM Ehsanipoor","year":"2008","unstructured":"Ehsanipoor RM, Chung JH, Clock CA, McNulty JA, Wing DA. A retrospective review of ampicillin-sulbactam and amoxicillin\u2009+\u2009clavulanate vs cefazolin\/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes. Am J Obstet Gynecol. 2008;198(5):e54\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"8341_CR14","doi-asserted-by":"publisher","first-page":"F187","DOI":"10.1136\/fn.89.2.F187","volume":"89","author":"A Al-Sabbagh","year":"2004","unstructured":"Al-Sabbagh A, Moss S, Subhedar N. Neonatal necrotising enterocolitis and perinatal exposure to coamoxyclav. BMJ Archives Disease Childhood-Fetal Neonatal Ed. 2004;89(2):F187-187.","journal-title":"BMJ Archives Disease Childhood-Fetal Neonatal Ed"},{"issue":"Suppl 6","key":"8341_CR15","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1016\/j.ajog.2003.10.402","volume":"189","author":"A Ghidini","year":"2003","unstructured":"Ghidini A, Goldberg L, Locatelli A, Doria V, Fedeli Tosco L, et al. Does co-amoxiclav in preterm prom increase the risk of necrotizing Enterocolitis (NEC)? A meta-analysis. Am J Obstet Gynecol. 2003;189(Suppl 6):S170. Abstract Review Only.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"8341_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000489677","volume":"114","author":"DJ Berkhout","year":"2018","unstructured":"Berkhout DJ, Klaassen P, Niemarkt HJ, de Boode WP, Cossey V, van Goudoever JB, et al. Risk factors for necrotizing enterocolitis: a prospective multicenter case-control study. Neonatology. 2018;114(3):277\u201384.","journal-title":"Neonatology"},{"issue":"10","key":"8341_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1651-2227.2003.tb02481.x","volume":"92","author":"TG Krediet","year":"2003","unstructured":"Krediet TG, Van Lelyveld N, Vijlbrief DC, Brouwers HAA, Kramer WLM, Fleer A, et al. Microbiological factors associated with neonatal necrotizing enterocolitis: protective effect of early antibiotic treatment. Acta Paediatr. 2003;92(10):1180\u20132.","journal-title":"Acta Paediatr"},{"key":"8341_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1112812","volume":"11","author":"A Cuna","year":"2023","unstructured":"Cuna A, Morowitz MJ, Sampath V. Early antibiotics and risk for necrotizing enterocolitis in premature infants: a narrative review. Front Pediatr. 2023;11:1112812.","journal-title":"Front Pediatr"},{"key":"8341_CR19","doi-asserted-by":"publisher","first-page":"1102884","DOI":"10.3389\/fped.2022.1102884","volume":"10","author":"DH Klerk","year":"2023","unstructured":"Klerk DH, van Avezaath LK, Loeffen EA, Hulscher JB, Kooi EM. Fetal\u2013neonatal exposure to antibiotics and NEC development: a systematic review and meta-analysis. Front Pead. 2023;10:1102884.","journal-title":"Front Pead"},{"issue":"1","key":"8341_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38156-7","volume":"14","author":"M Stocker","year":"2023","unstructured":"Stocker M, Klingenberg C, Nav\u00e9r L, Nordberg V, Berardi A, El Helou S, et al. Less is more: antibiotics at the beginning of life. Nat Commun. 2023;14(1):2423.","journal-title":"Nat Commun"},{"key":"8341_CR21","doi-asserted-by":"crossref","unstructured":"Winteler C, Ardabili S, Hodel M, Stocker M. A systematic review of perinatal antibiotic Stewardship \u2013 where we are, where to go? J Perinatol. 2025:1\u201312.","DOI":"10.1038\/s41372-025-02209-0"},{"issue":"11","key":"8341_CR22","doi-asserted-by":"publisher","first-page":"e2243691","DOI":"10.1001\/jamanetworkopen.2022.43691","volume":"5","author":"E Giannoni","year":"2022","unstructured":"Giannoni E, Dimopoulou V, Klingenberg C, Nav\u00e9r L, Nordberg V, Berardi A, et al. Analysis of antibiotic exposure and early-onset neonatal sepsis in Europe, North America, and Australia. JAMA Netw Open. 2022;5(11):e2243691\u20132243691.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"8341_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000226604","volume":"97","author":"A Van Den Hoogen","year":"2009","unstructured":"Van Den Hoogen A, Gerards LJ, Verboon-Maciolek MA, Fleer A, Krediet TG. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology. 2009;97(1):22\u20138.","journal-title":"Neonatology"},{"key":"8341_CR24","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1542\/peds.2007-2171","volume":"121","author":"MJ Bizzarro","year":"2008","unstructured":"Bizzarro MJ, Dembry L-M, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics. 2008;121:689\u201396.","journal-title":"Pediatrics"},{"issue":"4","key":"8341_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJMoa012657","volume":"347","author":"BJ Stoll","year":"2002","unstructured":"Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002;347(4):240\u20137.","journal-title":"N Engl J Med"},{"issue":"5","key":"8341_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1542\/peds.2010-2217","volume":"127","author":"BJ Stoll","year":"2011","unstructured":"Stoll BJ, Hansen NI, S\u00e1nchez PJ, Faix RG, Poindexter BB, Van Meurs KP, et al. Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics. 2011;127(5):817\u201326.","journal-title":"Pediatrics"},{"issue":"7","key":"8341_CR27","doi-asserted-by":"publisher","first-page":"e200593","DOI":"10.1001\/jamapediatrics.2020.0593","volume":"174","author":"BJ Stoll","year":"2020","unstructured":"Stoll BJ, Puopolo KM, Hansen NI, S\u00e1nchez PJ, Bell EF, Carlo WA, et al. Early-onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies. JAMA Pediatr. 2020;174(7):e200593\u2013200593.","journal-title":"JAMA Pediatr"},{"issue":"16","key":"8341_CR28","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.3109\/14767058.2014.972928","volume":"28","author":"H Jeong","year":"2015","unstructured":"Jeong H, Han SJ, Yoo HN, Choi SJ, Oh SY, Kim YJ, et al. Comparison of changes in etiologic microorganisms causing early-onset neonatal sepsis between preterm labor and preterm premature rupture of membranes. The Journal of Maternal-Fetal & Neonatal Medicine. 2015;28(16):1923\u20138.","journal-title":"The Journal of Maternal-Fetal & Neonatal Medicine"},{"key":"8341_CR29","doi-asserted-by":"crossref","unstructured":"Pormohammad A, Nasiri MJ, Azimi T. Prevalence of antibiotic resistance in Escherichia coli strains simultaneously isolated from humans, animals, food, and the environment: a systematic review and meta-analysis. Infect Drug Resist. 2019:1181\u201397.","DOI":"10.2147\/IDR.S201324"},{"issue":"3","key":"8341_CR30","doi-asserted-by":"publisher","first-page":"F257","DOI":"10.1136\/archdischild-2014-306213","volume":"100","author":"Y Dong","year":"2015","unstructured":"Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Archives Disease Childhood-Fetal Neonatal Ed. 2015;100(3):F257-63.","journal-title":"Archives Disease Childhood-Fetal Neonatal Ed"},{"issue":"1","key":"8341_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cmi.2023.07.023","volume":"30","author":"N Russell","year":"2024","unstructured":"Russell N, Barday M, Okomo U, Dramowski A, Sharland M, Bekker A. Early-versus late-onset sepsis in neonates\u2013time to shift the paradigm? Clin Microbiol Infect. 2024;30(1):38\u201343.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"8341_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3346\/jkms.2011.26.2.284","volume":"26","author":"GH Shim","year":"2011","unstructured":"Shim GH, Kim SD, Kim HS, Kim ES, Lee HJ, Lee JA, et al. Trends in epidemiology of neonatal sepsis in a tertiary center in Korea: a 26-year longitudinal analysis, 1980\u20132005. J Korean Med Sci. 2011;26(2):284\u20139.","journal-title":"J Korean Med Sci"},{"issue":"2","key":"8341_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/2249-4847.96753","volume":"1","author":"AJ Shah","year":"2012","unstructured":"Shah AJ, Mulla SA, Revdiwala SB. Neonatal sepsis: high antibiotic resistance of the bacterial pathogens in a neonatal intensive care unit of a tertiary care hospital. J Clin Neonatol. 2012;1(2):72\u20135.","journal-title":"J Clin Neonatol"},{"issue":"11","key":"8341_CR34","first-page":"2511","volume":"7","author":"CM Sharma","year":"2013","unstructured":"Sharma CM, Agrawal RP, Sharan H, Kumar B, Sharma D, Bhatia SS. Neonatal sepsis: bacteria & their susceptibility pattern towards antibiotics in neonatal intensive care unit. J Clin Diagn Res. 2013;7(11):2511\u20133.","journal-title":"J Clin Diagn Res"},{"issue":"5","key":"8341_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1080\/14767058.2020.1732342","volume":"35","author":"J Wang","year":"2022","unstructured":"Wang J, Zhang H, Yan J, Zhang T. Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis. J Matern Fetal Neonatal Med. 2022;35(5):861\u201370.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"8341_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jogoh.2018.12.007","volume":"48","author":"M Merello","year":"2019","unstructured":"Merello M, Lotte L, Gonfrier S, dit Trolli SE, Casagrande F, Ruimy R, et al. Enterobacteria vaginal colonization among patients with preterm premature rupture of membranes from 24 to 34 weeks of gestation and neonatal infection risk. J Gynecol Obstet Hum Reprod. 2019;48(3):187\u201391.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"13","key":"8341_CR37","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1055\/s-0035-1552935","volume":"32","author":"MF Wolf","year":"2015","unstructured":"Wolf MF, Miron D, Peleg D, Rechnitzer H, Portnov I, Salim R, et al. Reconsidering the current preterm premature rupture of membranes antibiotic prophylactic protocol. Am J Perinatol. 2015;32(13):1247\u201350.","journal-title":"Am J Perinatol"},{"issue":"8","key":"8341_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062990","volume":"12","author":"ME Jonduo","year":"2022","unstructured":"Jonduo ME, Vallely LM, Wand H, Sweeney EL, Egli-Gany D, Kaldor J, et al. Adverse pregnancy and birth outcomes associated with Mycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum: a systematic review and meta-analysis. BMJ Open. 2022;12(8):e062990.","journal-title":"BMJ Open"},{"issue":"2","key":"8341_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/1040841X.2020.1736986","volume":"46","author":"KE Sprong","year":"2020","unstructured":"Sprong KE, Mabenge M, Wright CA, Govender S. Ureaplasma species and preterm birth: current perspectives. Crit Rev Microbiol. 2020;46(2):169\u201381.","journal-title":"Crit Rev Microbiol"},{"issue":"11","key":"8341_CR40","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/jdv.15146","volume":"32","author":"P Horner","year":"2018","unstructured":"Horner P, Donders G, Cusini M, Gomberg M, Jensen JS, Unemo M. Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? \u2013 a position statement from the European STI guidelines editorial board. J Eur Acad Dermatol Venereol. 2018;32(11):1845\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"8341_CR41","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1542\/peds.2008-1113","volume":"123","author":"IN Olomu","year":"2009","unstructured":"Olomu IN, Hecht JL, Onderdonk AO, Allred EN, Leviton A. Extremely low gestational age newborn study Investigators. Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of Singleton pregnancies that end before 28 weeks of gestation. Pediatrics. 2009;123(5):1329\u201336.","journal-title":"Pediatrics"},{"issue":"3","key":"8341_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1515\/jpm.2011.022","volume":"39","author":"DC Kasper","year":"2011","unstructured":"Kasper DC, Mechtler TP, Bohm J, Petricevic L, Gleiss A, Spergser J, et al. In utero exposure to Ureaplasma spp. is associated with increased rate of bronchopulmonary dysplasia and intraventricular hemorrhage in preterm infants. J Perinat Med. 2011;39(3):331\u20136.","journal-title":"J Perinat Med"},{"issue":"2","key":"8341_CR43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/jac\/dkw425","volume":"72","author":"ML Beeton","year":"2017","unstructured":"Beeton ML, Spiller OB. Antibiotic resistance among Ureaplasma spp. isolates: cause for concern? J Antimicrob Chemother. 2017;72(2):330\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"8341_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxae308","volume":"136","author":"WT Ramaloko","year":"2025","unstructured":"Ramaloko WT, Maningi NE, Sekyere JO. Global prevalence, resistance rates, and underlying resistance mechanisms of clinical Mycoplasma and Ureaplasma species. J Appl Microbiol. 2025;136(1):lxae308.","journal-title":"J Appl Microbiol"},{"key":"8341_CR45","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.2147\/IDR.S405286","volume":"16","author":"S Zhang","year":"2023","unstructured":"Zhang S, Xu K, Liu SX, Ye XL, Huang P, Jiang HJ. Retrospective analysis of Azithromycin-resistant Ureaplasma urealyticum and Mycoplasma hominis cervical infection among pregnant women. Infect Drug Resist. 2023;16:3541\u20139.","journal-title":"Infect Drug Resist"},{"issue":"6","key":"8341_CR46","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ajog.2021.12.262","volume":"226","author":"RD Seaman","year":"2022","unstructured":"Seaman RD, Kopkin RH, Turrentine MA. Erythromycin vs azithromycin for treatment of preterm prelabor rupture of membranes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226(6):794\u2013801.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"8341_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08102-5","volume":"23","author":"W Fan","year":"2023","unstructured":"Fan W, Wang Q, Liang Z, Wang J, Zhang L. Efficacy of azithromycin in treating Ureaplasma urealyticum: a systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):163.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"8341_CR48","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/1471-0528.17081","volume":"129","author":"E Lorthe","year":"2022","unstructured":"Lorthe E, Letouzey M, Torchin H, Foix L, Helias L, Gras-le Guen C, Benhammou V, et al. Antibiotic prophylaxis in preterm premature rupture of membranes at 24\u201331 weeks\u2019 gestation: perinatal and 2-year outcomes in the EPIPAGE-2 cohort. BJOG. 2022;129(9):1560\u201373.","journal-title":"BJOG"},{"key":"8341_CR49","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ijid.2020.05.005","volume":"96","author":"MF Wolf","year":"2020","unstructured":"Wolf MF, Sgayer I, Miron D, Krencel A, Sheffer VF, Idriss SS, et al. A novel extended prophylactic antibiotic regimen in preterm pre-labor rupture of membranes: a randomized trial. Int J Infect Dis. 2020;96:254\u20139.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"8341_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2023.100900","volume":"5","author":"I Sgayer","year":"2023","unstructured":"Sgayer I, Francis YN, Miron D, Shprits E, Sheffer VF, Rechnitzer H, et al. Compared perinatal outcomes of two prophylactic antibiotic regimens for preterm premature rupture of membranes: a randomized controlled trial. American Journal of Obstetrics & Gynecology MFM. 2023;5(5):100900.","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"issue":"7","key":"8341_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2023.100978","volume":"5","author":"LL Lin","year":"2023","unstructured":"Lin LL, Hung JN, Shiu SI, Su YH, Chen WC, Tseng JJ. Efficacy of prophylactic antibiotics for preterm premature rupture of membranes: a systematic review and network meta-analysis. American Journal of Obstetrics & Gynecology MFM. 2023;5(7):100978.","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"issue":"3","key":"8341_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0146-0005(03)00016-8","volume":"27","author":"BM Mercer","year":"2003","unstructured":"Mercer BM, Goldenberg RL, Das AF, Thurnau GR, Bendon RW, Miodovnik M, et al. What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes. Semin Perinatol. 2003;27(3):217\u201330.","journal-title":"Semin Perinatol"},{"issue":"5","key":"8341_CR53","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1515\/jpm-2017-0027","volume":"46","author":"M Tchirikov","year":"2018","unstructured":"Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J, Naberezhnev Y, Winarno, Andreas S, Seliger G. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 2018;46(5):465\u201388.","journal-title":"J Perinat Med"},{"issue":"3","key":"8341_CR54","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ajog.2009.06.049","volume":"201","author":"TP Waters","year":"2009","unstructured":"Waters TP, Mercer BM. The management of preterm premature rupture of the membranes near the limit of fetal viability. Am J Obstet Gynecol. 2009;201(3):230\u201340.","journal-title":"Am J Obstet Gynecol"},{"key":"8341_CR55","doi-asserted-by":"crossref","unstructured":"Sorrenti S, Di Mascio D, Khalil A, D\u2019ANTONIO F, Rizzo G, Zullo F et al. Outcome of prelabor rupture of membranes before or at the limit of viability: systematic review and meta-analysis. American journal of obstetrics & gynecology MFM. 2024;101370.","DOI":"10.1016\/j.ajogmf.2024.101370"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08341-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-08341-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-08341-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T11:03:09Z","timestamp":1763550189000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-08341-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8341"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-08341-1","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"19 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee \u201cEthikkommission Nordwest- und Zentralschweiz (EKNZ)\u201d in Basel, Switzerland (Project-ID 2023\u2009\u2212\u200901319, date of approval July 14, 2023) and was performed in accordance with the Declaration of Helsinki. All participants signed our hospital`s general informed consent form, which allows the use of their health-related data and samples for research purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1238"}}